JAMA Network
About The Study: Valacyclovir, an antiviral medication, was not efficacious with cognitive worsening for the primary outcome and it is not recommended to treat individuals with early symptomatic Alzheimer disease and herpes simplex virus seropositivity.
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
